Ernesto Aycardi

Ernesto Aycardi is an experienced pharmaceutical executive currently serving as Head Global Development Organization and Chief Development Officer at Kyowa Kirin Co., Ltd. since April 2021. Previously, Ernesto held the position of Chief Medical Officer at Xenon Pharmaceuticals Inc. from March 2018 to April 2021. Their extensive background includes roles such as Vice President at Teva Pharmaceuticals, where responsibilities encompassed global clinical trial execution and data management, Vice President and Therapeutical Area Head at EMD Serono, Inc., and various leadership positions in clinical development at Biogen Idec and Merck & Co., where Ernesto oversaw multiple therapeutic areas including neurology and pain management. Ernesto began their medical career as a clinical neurologist at CAFAM and Hospital Militar Central. Academic credentials include a degree from Universidad Nacional de Colombia.